TeloRNA Detection for Stem Cell Pluripotency Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for maintaining embryonic stem cells in an undifferentiated state are challenging due to the irreversible nature of differentiation, and existing pluripotency markers fail to distinguish between undifferentiated and partially differentiated cells, limiting their therapeutic potential.
Innovation Solution
The discovery of a novel cytologic mark, teloRNA, associated with pluripotency and cell health, using a Cot-1 or telomeric nucleic acid probe for hybridization, allows for the identification of undifferentiated stem cells by detecting specific RNA marks, enabling the assessment of differentiation status and cell health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Difficulty of detecting and measuring
If pluripotent stem cell markers are used to identify undifferentiated cells, then the ability to detect stem cells is improved, but the precision to distinguish undifferentiated from partially differentiated cells deteriorates
Solution Approach 1:
The patent segments the detection approach by using multiple distinct markers (OCT4, NANOG, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81) rather than relying on a single marker. This segmentation allows for more granular classification of stem cell differentiation states, enabling differentiation between undifferentiated, partially differentiated, and differentiated cells through the presence or absence of specific marker combinations.
Solution Approach 2:
The patent changes the detection parameters by employing a multi-marker panel with specific expression patterns. Each marker provides a different parameter for assessment, and the combination of these parameters creates a more precise profile for distinguishing undifferentiated stem cells from partially differentiated cells, overcoming the limitations of single-marker approaches.
2Adaptability or versatility
If stem cells are maintained in undifferentiated state in culture, then their therapeutic potential is improved, but the stability of the undifferentiated state deteriorates due to spontaneous differentiation
Solution Approach 1:
The patent applies preliminary action by establishing a comprehensive multi-marker detection system before differentiation occurs. This allows for early identification of cells that are beginning to differentiate, enabling researchers to take corrective measures to maintain the undifferentiated state or to selectively isolate truly undifferentiated cells before they undergo irreversible differentiation.
Solution Approach 2:
The patent implements feedback by using the multi-marker panel to continuously monitor the differentiation status of stem cell cultures. The expression patterns of OCT4, NANOG, SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81 provide real-time feedback on cell state, allowing for adjustments in culture conditions or selection strategies to maintain therapeutic quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively identifies undifferentiated stem cells before differentiation initiation, monitors pluripotency, and assesses cell viability, differentiating between healthy and diseased cells, thereby maintaining stem cell potency and health.
Implementation Method 1
contacting the stem cell with a Cot-1 or telomeric nucleic acid probe under conditions for hybridization of the Cot-1 or telomeric nucleic acid probe to a teloRNA mark in the nucleus of the stem cell
Data Source
AI summary
Disclosed herein are methods and compositions for the identification of teloRNA marks to assess the differentiation status of an individual stem cell or a population of stem cells, to diagnose whether and to what extent a stem cell or stem cell culture has already initiated cell differentiation, and to monitor the differentiation status of an individual stem cell or a stem cell culture during passage. The use of these methods and compositions to monitor the pluripotency and differentiation status of a stem cell or stem cell culture during differentiation enables the identification of undifferentiated and pluripotent stem cells prior to the initiation of differentiation. The methods and compositions can also be used to assess and maintain cell viability; to identify cells or a population of cells that are in a state of poor cell health; and to reduce cell growth or treat a diseased cell including, for example, pre-cancerous cells, cancerous cells, apoptotic cells, aging cells, cells undergoing stress, and otherwise diseased or dysfunctional cells.